Overview
Location
Norway
Total raised
$7M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 3, 2026 | Vitroscope Raises $7 Million To Scale Live-Tissue Drug Discovery Platform | Vitroscope has raised $7 million to expand its live-tissue research platform for studying immune activity, treatment responses, and disease mechanisms over time. The financing consists of a $5 million seed round co-led by Cerberus Ventures ... |
| Nov 3, 2026 | Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data | Vitroscope, a biotech company developing perfusion platforms to study immune activity, treatment responses and disease mechanisms in real time, has raised $7 million, comprising a $5 million seed round and $2 million in non-dilutive funding... |
Reviews 0
FAQ about Vitroscope
How much funding has Vitroscope raised?
Vitroscope has raised $7M in total across 1 funding round.
What has the press written about Vitroscope?
Parsers VC has collected 3 articles mentioning Vitroscope, among them “Vitroscope Raises $7 Million To Scale Live-Tissue Drug Discovery Platform” (Nov 3, 2026) and “Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data” (Nov 3, 2026).
Is Vitroscope still active?
Yes, Vitroscope is active; its latest activity on Parsers VC dates from Nov 3, 2026.